Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Updated: US FDA Sending Pazdur Back To Oncology Office
Dec 04 2025
•
By
Derrick Gingery
Richard Pazdur will return to his oncology roles for his remaining time at the FDA. • Source: Screenshot of internet broadcast
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from United States